M&A-1

M&A DEAL OF THE YEAR


This award recognises the teams and organisations who have executed a truly transformational and high value M&A deal for both the company and the wider industry. 

Qualifying criteria
 
- The lead company must be a European Life Science company
- Open to private, public companies, pharma, commercial leaders or big tech
- Deal must be an M&A deal NOT a license, partnership or alliance
- Deal to have completed in the period between 1 September 2019 and 1 September 2020

Judges will be paying particular attention to:

- Uniqueness or novelty of deal strategy / terms and structure
- Level of value creation / size of deal
- Strength of acquirers existing pipeline / synergy with existing portfolio
- Potential game / industry changing implications within next 12-months
- Post-deal performance
 

SUBMIT AN ENTRY

BUY TICKETS AND TABLES